Log in or Sign up for Free to view tailored content for your specialty!
Stroke/Vascular Neurology News
Q&A: New stroke guidance highlights risk for women with endometriosis, early menopause
New guidance on primary prevention of stroke from the American Heart Association and American Stroke Association states women with endometriosis and early menopause are at higher risk, requiring a thorough history and tailored management.
SGLT2s, GLP-1s may improve mortality, CV event risk after stroke
CHICAGO — Use of an SGLT2 inhibitor or GLP-1 receptor agonist after stroke may improve mortality and lower subsequent risk for heart attack and another stroke, a speaker reported.
Log in or Sign up for Free to view tailored content for your specialty!
Blood pressure drug may lower risk for post-stroke epilepsy
LOS ANGELES — Individuals with hypertension and stroke who were prescribed angiotensin receptor blockers had a significantly lower risk for post-stroke epilepsy than those prescribed other antihypertension medications, according to new research.
Cardiovascular factors, including hypertension, associated with risk for severe stroke
Hypertension, atrial fibrillation and smoking were most strongly associated with an increased risk for severe compared with non-severe stroke, according to analysis from the INTERSTROKE study.
Rivaroxaban fails to prevent cognitive decline, stroke in younger adults with AF
CHICAGO — In the BRAIN-AF trial, daily rivaroxaban did not reduce the incidence of cognitive decline, stroke or transient ischemic attack, compared with placebo, among younger patients with atrial fibrillation and low stroke risk.
Cardiovascular health in middle age strongly associated with brain health in later years
Cardiovascular health of middle-aged adults was significantly associated with the risk of poor brain health later in life, according to a study published in Neurology.
Catch up on the latest stroke research in observance of World Stroke Day
October 29 is World Stroke Day, which aims to raise awareness of the condition and how to prevent it.
Oral semaglutide prevents CV events in people with diabetes and heart disease, CKD
Oral semaglutide demonstrated an approximately 14% reduction in major adverse CV events compared with standard care along in patients with diabetes, CVD and/or kidney disease, according to the top-line results of the phase 3 SOUL trial.
New stroke primary prevention guideline calls for more screening of risk factors
The new guideline on primary prevention of stroke from the American Heart Association and American Stroke Association calls for more screening of risk factors such as high BP, high cholesterol and high blood glucose.
5% of older adults start benzodiazepine after acute stroke, despite link to cognitive risk
Nearly 5% of older adults initiate benzodiazepine after discharge for acute ischemic stroke, half of which receive up to a 30-day supply, despite known risks for cognitive decline, researchers reported in Stroke.
-
Headline News
‘Evidence-based and ethically sound’ definition of long COVID still ‘too sensitive’
May 30, 202513 min read -
Headline News
‘A long-term American disadvantage’: Over 14 million excess deaths in US since 1980
May 30, 20253 min read -
Headline News
Nephrologists should be involved in gout management with CKD
May 29, 20255 min read
-
Headline News
‘Evidence-based and ethically sound’ definition of long COVID still ‘too sensitive’
May 30, 202513 min read -
Headline News
‘A long-term American disadvantage’: Over 14 million excess deaths in US since 1980
May 30, 20253 min read -
Headline News
Nephrologists should be involved in gout management with CKD
May 29, 20255 min read